Alternatively, CD11c−CCR2−CX3CR1− macrophages or M2 macrophages induced by IL-4, IL-13, IL-10 or TGF-β show an anti-inflammatory profile in experimental colitis and are decreased in the colons of patients with active IBD [26, 99–101]. This evidence concerns the gene TGFB1 and inflammatory bowel disease.